期刊文献+

E-cad、LN、ColⅣ和PCNA与乳腺癌浸润转移的关系 被引量:2

The relationship between E-cad,LN,Col Ⅳ,PCNA and in infiltration,metastasis in breast cancer
下载PDF
导出
摘要 目的探讨细胞黏附分子钙黏蛋白(E-cad)、层粘连蛋白(LN)、Ⅳ型胶原蛋白(ColⅣ)和增殖细胞核抗原(PCNA)表达与乳腺癌的关系。方法采用免疫组织化学技术对80例乳腺癌E-cad、LN、ColⅣ和PCNA的表达进行检测。结果 E-cad低表达率与乳腺癌组织类型、分化程度、临床分期、转移及生存期短显著相关(P<0.01);基底膜缺损程度在分化低、临床Ⅲ~Ⅳ期、有转移及生存期<5年的乳腺癌组,显著高于分化高、临床Ⅰ~Ⅱ期、无转移及生存期≥5年组(P<0.01),而PCNA的表达在前组中显著增高(P<0.01)。结论 E-cad、LN、ColⅣ和PCNA的表达可作为临床判断乳腺癌浸润转移及预后的重要指标。 Objective To discuss the relationship between the expressions of E-cadherin (E-cad), laminin(LN), collagen IV (CollV), proliferating cell nuclear antigen (PCNA) and the prognosis of the breast cancer. Methods The expressions of Ecad, LN, Coliv and PCNA in 80 cases of breast cancer were measured by immunohistochemical technique. Results There was a significant difference between the low expressive rate of E-cad, and histologic types, differential grades, clinical stages, metastasis and short survival periods in breast cancer (P 〈 0.01); there were many more defects in the basic membrance of breast cancer for the poor differential grades, stages Ⅲ-Ⅳ, metastases and survival time 〈 5 years than that for the high differential grades, stages Ⅰ- Ⅱ, no metastases and survival time ≥ 5 years (P 〈 0.01), on the other hand, signifi- cant increases of PCNA expression were showed in the former ones (P 〈 0.01). Conclusion The expressions of E-cad, LN, ColⅣ and PCNA in breast cancer can be used as important indicates for the judgements of infiltration, spread and prognosis of breast cancer.
出处 《中国当代医药》 2012年第23期146-147,149,共3页 China Modern Medicine
关键词 乳腺癌 钙黏蛋白 层黏蛋白 Ⅳ型胶原 增殖细胞核抗原 Breast cancer E-cadherin Laminin Collagen Ⅳ Proliferating cell nuclear antigen
  • 相关文献

参考文献7

二级参考文献34

共引文献47

同被引文献18

  • 1刘阳,王立国.保乳手术治疗早期乳腺癌的临床分析[J].实用医学杂志,2006,22(20):2411-2412. 被引量:28
  • 2Ferlay J,Shin HR,Bray F,et al.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J].Int J Cancer,2010,127( 12): 2893-2917. 被引量:1
  • 3Kanai T, Hirohashi S, Upton MP, et al.Pathology of small hepatocel- lular carcinoma.A proposal for a new gross classification[J].Cancer, 1987,60(4) : 810-819. 被引量:1
  • 4Yuki K,Hirohashi S,Sakamoto M,et al. Growth and spread of hepa- tocellular carcinoma.A review of 240 consecutive autopsy cases[J]. Cancer, 1990,66(10) : 2174-2179. 被引量:1
  • 5Yamashita T,Forgues M,Wang W,et al.EpCAM and alpha-fetopro- tein expression defines novel prognostic subtypes of hepatocellular carcinoma[ J ].Cancer Res, 2008,68 (5) : 1451-1461. 被引量:1
  • 6Bringuier PP,Umbas R, Schaafsma HE, et al.Decreased E-cadherin irrtmunoreactivity correlates with poor survival in patients with blad- der tumors[J].Cancer Res, 1993,53(14):3241-3245. 被引量:1
  • 7Genda T, Sakamoto M, Ichida T, et al.Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahep- atic metastasis of human hepatocellular carcinoma[J].Hepatology, 1999,30(4) : 1027-1036. 被引量:1
  • 8Maetzel D,Denzel S,Mack B,et al.Nuclear signalling by tumour- associated antigen EpCAM[J].Nat Cell Biol,2009,11(2) : 162-171. 被引量:1
  • 9Ralhan R, He HC, So AK,et al.Nuclear and cytoplasmic accumula- tion of Ep-ICD is frequently detected in human epithelial cancers [ J ].PLoS One,2010,5( 11 ):e14130. 被引量:1
  • 10Baeuerle PA,Gires O.EpCAM (CD326)finding its role in cancer[J]. Br J Cancer,2007,96(3):417-423. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部